Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 GBX | 0.00% |
|
+16.13% | -7.69% |
06-17 | Cizzle says CIZ1B biomarker test picked for "major" US cancer study | AN |
04-30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.69% | 9.04M | |
+38.36% | 52.73B | |
+36.73% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- PSL Stock
- News Cizzle Biotechnology Holdings Plc
- Earnings Flash (CIZ.L) CIZZLE BIOTECHNOLOGY Reports FY22 Loss GBX-0.30